Article: NAMING NEW DRUGS: COSTLY, COMPLEX

00-00-0000
NAMING NEW DRUGS: COSTLY, COMPLEX -- SAFETY QUESTIONS MUST BE OVERCOME By LEWIS KRAUSKOPF, Staff Writer Date: 01-15-2002, Tuesday Section: NEWS Edition: All Editions -- Two Star B, Two Star P, One Star B

Zyrtec. Vioxx. Prozac.

The names may sound like planets in a science fiction tale, but they're really brand names for prescription medicines that have become part of the medical lexicon.

Naming drugs is no random act. It takes pharmaceutical companies years and costs them about $2.25 million to name each medicine. They hire consultants to find snappy sounds, rule out overlaps, navigate legal and regulatory channels, and hone market strategies for their drug ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!